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INTRODUCTION
In the first few days following an acute ST-segment elevation myocardial infarction (STEMI), cardiac magnetic resonance (MR) imaging can assess regional/global left ventricular function, myocardial infarct (MI) size, the 'area-at-risk' (AAR) 1, 2 , the presence of microvascular obstruction (MVO) 3 and intra-myocardial hemorrhage 4 features which not only provide important prognostic information but may also serve as surrogate endpoints in cardioprotection studies. These omit a key biological parameter, cardiac metabolism, currently inaccessible by conventional MR imaging.
The recent availability of hybrid Positron Emission Tomography and Magnetic
Resonance (PET-MR) imaging offers the unique advantage of simultaneous tissue characterization by MR to be combined with the metabolic insights provided by PET, without requiring an acutely unwell patient to undergo two separate scans, and obviating complex and potentially imprecise co-registration of separately acquired PET and MR datasets. To date, there has been limited experience with hybrid PET-MR imaging of the heart [5] [6] [7] [8] . T2-weighted MR imaging of myocardial edema has been used to quantify the AAR in STEMI patients, a pre-requisite for calculating myocardial salvage -a critical measure of efficacy in cardioprotection studies 1, 9, 10 . Hybrid PET-MR imaging of the reperfused heart therefore, provides the opportunity to investigate cardiac metabolism in salvaged, reversibly injured myocardium within the AAR. The area of reduced myocardial glucose uptake has recently been shown to overestimate the AAR assessed by endocardial surface area (ESA). 11 We hypothesized that the area of reduced myocardial glucose uptake would closely match the area-at-risk (AAR) delineated by T2-mapping in STEMI patients treated by PPCI.
METHODS

Study population
We performed a single-center study of 22 STEMI patients treated by PPCI recruited over a 7-month period. Study exclusion criteria were as follows: ≤45 years of age (to attenuate any theoretical higher risk from ionizing radiation in younger patients);
diabetes mellitus (as pre-existing metabolic/glycemic derangement may affect clarity of initial results); previous MI; and standard recognized contraindications to MR. All eligible patients provided informed and written consent. The study was approved by the UK National Research Ethics Service.
Hybrid PET-MR cardiac imaging protocol
Patients underwent hybrid PET-MR imaging at a median of 5 [4] [5] [6] days after PPCI using an integrated whole-body PET-MR (3.0 Tesla) scanner (Biograph mMR, Siemens Healthcare, Erlangen, Germany)( Figure 1) . A subset of patients underwent a follow-up scan at 12 months. 18 F-fluorodeoxyglucose (FDG) was used to assess resting myocardial glucose metabolism. Subjects fasted for a minimum of 6 hours followed by 75g of oral glucose 2 hours prior to the scan, and 45-60 minutes later, insulin was administered as previously described 12 , followed by intravenous FDG (mean activity of 248±15 MBq) at a mean of 73±12 minutes prior to PET images acquisition.
A standard cardiac MR imaging protocol 13 including cine imaging, and T2-mapping and late gadolinium enhancement (LGE) imaging performed simultaneously with the FDG-PET acquisition following single breath-hold attenuation correction (AC).
LGE imaging was performed using a standard segmented 'fast low-angle shot' twodimensional inversion-recovery gradient echo sequence 10-15 minutes after the injection of Gadoterate meglumine (Gd-DOTA marketed as Dotarem, Guerbet S.A., Paris, France) at a dose of 0.1 mmol/kg and T2 maps (Works in Progress, software WIP #699, Siemens Healthcare, Frimley, UK) were acquired as previously described 14 . In brief, 3 single-shot images at different T2 preparation times (0ms, 24ms, and 55ms, respectively) using the following parameters were acquired: repetition time=3xR-R interval; acquisition matrix=116x192; flip angle=65°; slice thickness=6mm with 4mm gap; field of view adjusted according to subject size (320-400mm). Motion correction and fitting were performed to estimate coefficients of the decay function, which was subsequently used to estimate T2 relaxation times. An in-built specific color look-up table was used to output the final color T2 maps, consisting of pixel-wise T2 values. A full stack of short axis slices was acquired to cover the left ventricular (LV) from base to apex -each MR modality matching exactly the same slice position.
FDG-PET images were acquired with one bed position, gated by electrocardiography, and comprised three-dimensional isotropic image reconstruction (voxel size, 2x2x2 mm 3 ) using Poisson ordered-subset expectation maximization with 21 subsets and three iterations, a Gaussian filter with 5.0-mm full-width at half maximum, and a 344x344 image matrix to obtain summed average FDG-PET images. A four-compartment model PET attenuation map was calculated using the MR capabilities of the machine using fat-only and water-only Dixon-based sequences for automatic PET AC 15 .
Image analysis
Co-localization of the MI territory with FDG uptake
Co-localization of the MI territory with FDG uptake was evaluated using 'fused' FDG-
LGE images created by fusing individual end-diastolic LGE short-axis slices with the summed static FDG-PET images using OsiriX freeware (Version 5.8.5, Geneva, Switzerland). The fused images were then visually assessed to identify areas of LGE and reduced FDG uptake.
Quantification of AAR, MI size and FDG uptake
Quantification of LV volumes, LV mass, LV ejection fraction, AAR by T2-mapping, regions of reduced FDG uptake and MI size were performed using CVI 42 software (Version 5.1.0, Calgary, Canada). As described above, each end-diastolic LGE slice uptake as per the AHA model, normalized to the highest signal intensity for that patient set at 100%. A second method to quantify the reduction in FDG uptake in the infarctrelated territory was also performed by using a threshold of <50% on the acute scan polar maps. A threshold of ≥50% on the follow-up polar maps was used for identifying viable segments. 16 Segmental analysis was performed using CVI 42 software for early gadolinium enhancement (EGE), LGE and T2 maps and displayed according to the modified 16 segment (excluding the apex) American Heart Association (AHA) model 17 . The EGE images were visually analyzed by 2 experienced investigators and segments with a hypo-intense core were visually scored "0" or "1" for absence or presence of early MVO. Mean transmural extent of LGE was quantified for each short axis slice and mean segmental T2 values were also automatically generated displayed according to the modified 16 segments AHA model. Segmental wall motion analysis was visually performed by 2 experienced investigators and scored as "0" for normal; "1" for mild/moderate hypokinesis; "2" for severe hypokinesis; "3" for akinesis and "4" dyskinesis. 18 A reduction in segmental wall motion score of ≥ 1 at follow-up was defined as an improvement in segmental wall motion.
Coronary angiographic analysis
Coronary angiograms were analyzed by 2 independent experienced investigators using the BARI (Bypass Angioplasty Revascularisation Investigation) and the modified
APPROACH (Alberta Provincial Project for Outcome Assessment in Coronary Heart
Disease) coronary angiography jeopardy scores 19 to provide an MR-independent estimate of the AAR.
Statistical analysis
Continuous data were expressed as mean±SD or median [interquartile range] for
variables showing departure from a normal distribution. Categorical data were reported as frequencies and percentages. Intra-class correlation (ICC) coefficients for interobserver agreement 20 were calculated for the T2-mapping and FDG-PET quantification by using single measures in a two-way random model for absolute agreement. Paired tests were used to compare measurements made within the same patient using 2 techniques at 1 time point (e.g. AAR by T2-mapping and FDG-PET) or using the same technique at 2 time points (e.g. reduction in FDG uptake between the acute and followup scans). Pearson's correlation coefficient was used to assess inter-method correlation.
Bland-Altman analysis was performed to assess agreement and bias detection between methods and presented as bias±2SD. Variances between methods were compared using Pitman's test. Receiver Operating Characteristic (ROC) analyses were performed to assess the diagnostic performance for LGE, FDG and T2 on the acute scan for detecting viable myocardium and predicting segmental wall motion recovery. All statistical tests were two-tailed, and P <0.05 was considered statistically significant. Statistical analysis was performed using SPSS version 22 (IBM Corporation, Illinois, US). MedCalc version 15.6.1 (Medcalc Software Ostend, Belgium) was also used for ROC curve comparison using the method described by Delong et al 21 and for correlation coefficient comparison described by Hinkle et al 22 .
RESULTS
21 patients completed the full imaging protocol at a median of 5 [4] [5] [6] Table 1 . 12 patients had a follow-up scan at a median of 12 (11) (12) (13) (14) months following PPCI.
Area of reduced FDG uptake is larger than MI size by LGE-MR
From the fused FDG-LGE images, 20 out of 21 patients had reduced FDG uptake in the same territory of the MI location. The area of reduced FDG uptake was significantly larger than the area of LGE (37.2±11.6% with FDG-PET versus 22.3±11.7% with LGE-MR; P<0.001)( Table 2) . Figures 2 and 3 show representative images of patients with a transmural MI (minimal myocardial salvage) and a subendocardial MI (significant myocardial salvage), respectively.
Area of reduced FDG uptake delineates the AAR by T2-mapping
There was excellent per patient inter-observer agreement for the AAR by T2-mapping and manual delineation of reduced FDG uptake, with an ICC coefficient of 0.93 (95% CI 0.83-0.97; P<0.001) and 0.94 (95% CI 0.85-0.98; P<0.001), respectively. Figure 4 and Table 3 show the performance of the different thresholding techniques when compared to manual delineation of the area of reduced FDG uptake. The 2 SD thresholding technique performed best with excellent correlation and agreement (P=0.07, ICC 0.99, R 0.99, bias of -0.9±4.33%), and was used for subsequent analyses.
The area of reduced FDG uptake closely matched the AAR delineated by T2-mapping (37.2±11.6% with FDG-PET versus 36.3±12.2% with T2-mapping; P=0.10).
There was an excellent correlation and agreement between the area of reduced FDG uptake and the AAR by T2-mapping (R 0.98, bias 0.9±4.4%, no difference between their variances, P=0.28) (Figure 5a and b) . When using the 50% threshold on the polar maps to quantify the area of reduced FDG uptake, there was no difference when compared with the AAR by T2-mapping (37.8±16.9% with FDG-PET versus 36.3±12.2% with T2-mapping; P=0.10). The correlation between them was 0.90 but there was a wider limit of agreement on Bland Altman analysis (bias of 2.0±15.6%).
Furthermore, Pitman's test confirmed a difference in the AAR by the 2 methods (P<0.05). For patients with an AAR of < 35%, T2-mapping had a trend to give a higher AAR than FDG uptake whereas for an AAR of > 35%, T2 mapping tended to be lower that FDG uptake (Figure 5c and 5d).
Area of reduced FDG uptake compared to BARI and modified APPROACH scores
The area of reduced FDG uptake correlated well with the MR-independent estimates of the AAR using the BARI and modified APPROACH coronary angiography scores but 
Hybrid cardiac PET-MR follow-up scans
The area of reduced FDG uptake on the follow-up scans was significantly lower than (Table 4 ). Figure 7 illustrates the differences in FDG uptake between the acute and follow-up scans of two patients with different myocardial salvage.
Reduced FDG uptake in the remote myocardium
In one patient presenting with an acute inferior STEMI, there was an additional area of reduced FDG uptake in the remote myocardium within the non-obstructed left anterior descending (LAD) coronary artery, with the follow-up scan showing improved FDG uptake within this remote area (Figure 8 ). This patient was excluded from any comparison
given that there was reduced FDG uptake outside of the infarct-related territory.
Acute scans to assess viability
Using an FDG uptake of ≥50% to indicate viable myocardium on the follow-up scan, transmural LGE on the acute scan had a sensitivity of 88% and specificity of 90% and on the follow-up scan had a sensitivity of 94% and specificity of 90%. The optimal cutoff for FDG uptake on the acute scan was a value of ≥45%, giving a sensitivity of 85%
and specificity of 95% to identify viable myocardium on follow-up. T2 performed the least well compared with LGE and FDG with an AUC of 0.79, 95% CI 0.71 -0.87, and a cut-off value of 55ms had a sensitivity and specificity of 76%.
Segmental wall motion recovery
Segmental wall motion was assessed in the 12 patients with acute and follow-up scans.
4 segments were excluded (due to incidental chronic infarct). Out of the remaining 188 segments, 94 segments (50%) had no wall motion abnormalities. The remaining 94 segments had wall motion scores as follows: (1) 20 segments; (2) 23 segments; (3) 51 segments. There was a similar correlation between wall motion score and FDG uptake on both the acute and follow-up scans (R -0.59 versus R -0.65, P 0.51).
Out of 94 segments with abnormal wall motion, 19 segments (20%) had no LGE and had lower T2 values and higher FDG uptake than the 75 segments (80%) with the presence of LGE (T2: 48.9±5.1ms versus 57.2±8.1ms, P < 0.001; FDG uptake: 63±12 versus 42±17, P < 0.001). All segments with no LGE showed complete recovery of wall motion at one year. There was no correlation between the wall motion score and FDG uptake in these later segments (R -0.06, P=0.82).
Among the segments with LGE, 34 segments (45%) had <50% transmural LGE and 41 segments (55%) had ≥50% transmural LGE with no difference in T2 values between these 2 groups (T2: 55.7±8.1ms versus 58.4±7.9ms, P=0.18). However, FDG uptake was significantly lower in segments with ≥50% transmural LGE (FDG uptake for
LGE<50% 50±15 versus 35±16 for LGE>50%, P< 0.001) and these segments were also least likely to recover regional wall motion (LGE<50%: 27/34 -79% recovered wall motion compared with LGE≥50% 20/41 -49% recovered wall motion, P=0.006). 
DISCUSSION
Using hybrid cardiac PET-MR imaging in reperfused STEMI patients, we found that the area of reduced myocardial glucose uptake by FDG-PET imaging closely matched the AAR delineated by T2-mapping. In STEMI patients with minimal myocardial salvage the areas of reduced FDG uptake were confined to the areas of LGE, confirming that cardiac metabolism was impaired within the irreversibly injured myocardium within the MI. However, in patients with significant myocardial salvage the areas of reduced FDG uptake extended beyond the areas of LGE and closely matched the AAR delineated by T2-mapping. This demonstrates that in patients with significant myocardial salvage impaired cardiac metabolism was not confined to areas of irreversibly injured myocardium within the MI, but also included the reversibly injured salvaged myocardium within the AAR. In a subset of patients who had 12 month follow-up scans, the areas of reduced FDG uptake were significantly lower than those observed on the acute scans, and were now confined to the areas of LGE only. This demonstrates normalization of cardiac metabolism within reversibly injured salvaged myocardium in the AAR, leaving areas of reduced FDG uptake in irreversible (nonviable) tissue.
The reliable and accurate measurement of the AAR is required to assess myocardial salvage in clinical studies investigating novel cardioprotective interventions in reperfused STEMI patients. Cardiac MR allows the retrospective delineation of the AAR in STEMI patients treated by PPCI, and depends on the ability of T2-weighted and T2-mapping to delineate the extent of myocardial oedema within the AAR 23 . It has been validated by histology in animal MI models 24, 25 , and by angiography jeopardy scores 26 and myocardial SPECT imaging 2, 27 in STEMI patients.
An alternative method to estimate the AAR is to measure the ESA of LGE 19 . However, unlike T2-weighted and T2-mapping, ESA is unable quantify the AAR in patients with minimal or absent infarction. Furthermore ESA has been shown to underestimate the AAR in STEMI patients when compared to T2-weighted imaging 28 . This finding was confirmed in a recent study 11 , in which the area of reduced FDG uptake was shown to over-estimate the AAR delineated by the ESA in reperfused STEMI patients.
There is currently no gold standard method for accurately quantifying the reduction in FDG uptake, and so we used manual delineation by 2 blinded operators as our reference standard, and compared it to 6 other established thresholding techniques.
In this study, we found that a 2SD thresholding technique performed best for quantifying the areas of reduced myocardial glucose uptake. When using a threshold of 50% of peak -more conventional in the field of PET imaging -we found the limits of agreement between FDG-PET and T2 mapping were wide, likely due to the inherent differences in the 2 techniques used such as differences in spatial resolution and acquisition phase during the cardiac cycle.
The mechanism for the reduced FDG uptake observed in reversibly injured salvaged myocardium is not clear. Animal models have been used to elucidate the metabolic changes occurring in reversibly injured 29, 30 and stunned myocardium [31] [32] [33] but due to the different ischemia/reperfusion protocols used and different baseline metabolic state of the animals prior to FDG administration, results from these studies regarding glucose and free fatty acid metabolism varied. However, putting these studies into context, it may be plausible that the reversibly injured but stunned myocardium preferentially uptakes more glucose than free fatty acid following a period of fasting compared to the normal myocardium but has delayed glucose metabolism. Therefore, after an oral glucose load, the reversibly injured myocardium has a reduced FDG uptake but subsequently normalizes on the follow-up scan.
Although a threshold of ≥50% of FDG uptake has been used to identify viable myocardium in the setting of stable coronary artery disease (CAD), the utility of FDG uptake in the acute setting has not been extensively studied. We have provided further insights into the definition and performance of LGE and FDG to detect viability in the acute setting, using the FDG uptake on the corresponding follow-up scan as gold standard. Shirasaki et al 34 has previously suggested a cut-off of 40% to detect viable myocardium, but FDG PET imaging was performed 2 weeks post AMI, and they used segmental wall motion recovery as the definition for viability. Rischpler et al 8 used a cut-off of ≥50% in the acute setting but no follow-up FDG PET was performed for comparison. Therefore our study is the first to provide validation of FDG uptake in the acute AMI setting by using follow-up FDG as the gold standard for viability.
We have also provided important insights into segmental wall motion recovery following AMI. Dysfunctional segments without LGE showed increased edema and reduced glucose metabolism yet recovered completely. Dysfunctional segments with early MVO showed evidence of intramyocardial hemorrhage (IMH) and reduced glucose metabolism and were least likely to recovery wall motion. Segments with predominantly reversibly injured myocardium were equally edematous compared to segments with predominantly irreversibly injury myocardium but differed in glucose metabolism. T2 did not perform as well as LGE and FDG on the acute scan to predict functional recovery due to the paramagnetic properties of IMH reducing the T2 signal.
35
Despite only having a small number of segments without LGE but with wall motion abnormality, the lack of correlation between FDG uptake and wall motion score may by reduction in wall thickening giving rise to reduced FDG uptake appearance on the summed static FDG images.
Limitations of study
There were a number of exclusions in our study (diabetics, age <45 years old, previous MI, known contraindications for MR) and our findings are limited to a selected group of STEMI patients. Being a low volume PPCI center and compounded by the strict inclusion criteria, we managed to recruit a small number of patients. Follow-ups were 
Summary and conclusions
We have demonstrated that the area of reduced myocardial glucose uptake in reversibly injured salvaged myocardium closely matched the AAR delineated by T2-mapping.
Furthermore, FDG uptake, transmural extent of LGE and T2 values on the acute scan appear to predict subsequent myocardial viability and segmental wall motion recovery.
With the advent of novel biological tracers, hybrid cardiac PET-MR has the potential to provide further insights into the pathophysiology of acute MI and subsequent post-MI LV remodeling. uptake is substantially larger than the area of LGE indicating significant myocardial salvage. On the follow-up scan there is a significant reduction in the area of reduced FDG uptake which is now restricted to the infarct zone.
Figure 8: Reduced myocardial glucose uptake in remote myocardium
One study patient with a mid-right coronary artery STEMI had an area of reduced FDG uptake (white arrow) matching the inferior infarct by LGE (red arrow) and the AAR in the inferior LV wall by T2-mapping (black arrow). There was an additional area of reduced FDG uptake in the anterior and antero-septal walls (yellow arrows) in remote myocardium. The follow-up scan showed improvement in FDG uptake in the anterior and antero-septal walls of the remote myocardium.
